18F-FAPI PET/CT在检测局灶性炎症所致难治性支架内再狭窄方面优于18F-FDG:一例病例报告
本文报告一例74岁女性复发性支架内再狭窄患者,采用双示踪剂18F-FAPI与18F-FDG PET/CT检查,发现左前降支支架段局部放射性摄取增高,且18F-FAPI摄取较18F-FDG更强烈。提示支架周围活跃的成纤维细胞相关重塑与炎症相关机制,患者后续接受抗炎治疗而非再次血运重建。
要点
- 18F-FAPI PET/CT在检测支架段局灶性炎症方面显示较18F-FDG更高的摄取强度。
- 双示踪剂PET/CT提示支架周围成纤维细胞相关重塑参与难治性支架内再狭窄机制。
- 基于影像发现,患者接受抗炎治疗而非重复血运重建。
核心结论
- 18F-FAPI PET/CT在检测作为难治性支架内再狭窄病因的局灶性炎症方面优于18F-FDG PET/CT。
- 双示踪剂PET/CT提示支架周围活跃的成纤维细胞相关重塑与炎症相关机制。
研究设计与样本
- 病例报告,报告一例74岁女性复发性支架内再狭窄患者的双示踪剂18F-FAPI与18F-FDG PET/CT表现。
主要发现
- 双示踪剂18F-FAPI与18F-FDG PET/CT显示左前降支支架段局部放射性摄取增高。
- 18F-FAPI在左前降支支架段的摄取较18F-FDG更强烈。
临床怎么用
- 对于复发性支架内再狭窄患者,可考虑行双示踪剂18F-FAPI与18F-FDG PET/CT评估局灶性炎症活动。
- 若影像提示炎症相关机制,可考虑抗炎治疗而非重复血运重建。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inflammation-associated coronary artery disease (I-CAD) is a recognized yet underdiagnosed cause of refractory in-stent restenosis. Conventional imaging modalities often lack sensitivity for detecting focal inflammatory activity. A 74-year-old woman with recurrent ISR was admitted to our institution. Dual-tracer ¹⁸F-FAPI and ¹⁸F-FDG PET/CT revealed locally increased radiotracer uptake within the left anterior descending artery (LAD) stent segment, with more intense uptake on 18 F-FAPI than on 18 F-FDG. We present the dual-tracer PET/CT findings in this patient with recurrent in-stent restenosis, suggesting active peri-stent fibroblast-related remodeling and an inflammation-associated mechanism. The patient was subsequently managed with anti-inflammatory therapy rather than repeated revascularization.
引用
- Xie H, Han X, Mi H, et al. 18 F-FAPI Outperforms 18 F-FDG PET/CT in Detecting Focal Inflammation as a Cause of Refractory In-Stent Restenosis : A Case Report. Clin Nucl Med. 2026. PMID: 42257445. doi:10.1097/RLU.0000000000006563
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。